<div><p>Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease caused by mutations in the <i>IDS</i> gene, leading to a deficiency in the iduronate-2-sulfatase enzyme that is involved in heparan sulphate and dermatan sulphate catabolism. In constitutive form, MPS II is a multi-system disease characterised by progressive neurocognitive decline, severe skeletal abnormalities and hepatosplenomegaly. Although enzyme replacement therapy has been approved for treatment of peripheral organs, no therapy effectively treats the cognitive symptoms of the disease and novel therapies are in development to remediate this. Therapeutic efficacy and subsequent validation can be assessed using a variety of outcome measures t...
Mucopolysaccharidosis type I (MPS I) is the most common form of the MPS group of genetic diseases. M...
Mucopolysaccharidosis type I (MPS I) is an inherited α-L-iduronidase (IDUA, I) deficiency in which ...
Crown copyright © 2008 Published by Elsevier B.V.Mucopolysaccharidosis (MPS) IIIA, or Sanfilippo syn...
Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease caused by m...
Mucopolysaccharidosis (MPS) type IIIA or Sanfilippo syndrome is a lysosomal storage disorder charact...
The cause of neurodegeneration in MPS mouse models is the focus of much debate and what the underlyi...
Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natu...
Mucopolysaccharide diseases (MPS) are caused by deficiency of glycosaminoglycan (GAG) degrading enzy...
The mucopolysaccharidoses are a group of inherited metabolic diseases wherein undegraded substrate a...
Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natu...
Mucopolysaccharidosis type II (MPSII), or Hunter syndrome, is a devastating disorder associated with...
Mucopolysaccharide diseases (MPS) are caused by deficiency of glycosaminoglycan (GAG) degrading enzy...
Mucopolysaccharidosis type IIIA (MPS IIIA; Sanfilippo syndrome) is a lysosomal storage disorder char...
International audienceSevere progressive neurological paediatric disease mucopolysaccharidosis III t...
Mucopolysaccharidosis type IIIC (MPSIIIC) is a severe lysosomal storage disease caused by deficiency...
Mucopolysaccharidosis type I (MPS I) is the most common form of the MPS group of genetic diseases. M...
Mucopolysaccharidosis type I (MPS I) is an inherited α-L-iduronidase (IDUA, I) deficiency in which ...
Crown copyright © 2008 Published by Elsevier B.V.Mucopolysaccharidosis (MPS) IIIA, or Sanfilippo syn...
Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease caused by m...
Mucopolysaccharidosis (MPS) type IIIA or Sanfilippo syndrome is a lysosomal storage disorder charact...
The cause of neurodegeneration in MPS mouse models is the focus of much debate and what the underlyi...
Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natu...
Mucopolysaccharide diseases (MPS) are caused by deficiency of glycosaminoglycan (GAG) degrading enzy...
The mucopolysaccharidoses are a group of inherited metabolic diseases wherein undegraded substrate a...
Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natu...
Mucopolysaccharidosis type II (MPSII), or Hunter syndrome, is a devastating disorder associated with...
Mucopolysaccharide diseases (MPS) are caused by deficiency of glycosaminoglycan (GAG) degrading enzy...
Mucopolysaccharidosis type IIIA (MPS IIIA; Sanfilippo syndrome) is a lysosomal storage disorder char...
International audienceSevere progressive neurological paediatric disease mucopolysaccharidosis III t...
Mucopolysaccharidosis type IIIC (MPSIIIC) is a severe lysosomal storage disease caused by deficiency...
Mucopolysaccharidosis type I (MPS I) is the most common form of the MPS group of genetic diseases. M...
Mucopolysaccharidosis type I (MPS I) is an inherited α-L-iduronidase (IDUA, I) deficiency in which ...
Crown copyright © 2008 Published by Elsevier B.V.Mucopolysaccharidosis (MPS) IIIA, or Sanfilippo syn...